These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vasorin stimulates malignant progression and angiogenesis in glioma. Liang W; Guo B; Ye J; Liu H; Deng W; Lin C; Zhong X; Wang L Cancer Sci; 2019 Aug; 110(8):2558-2572. PubMed ID: 31215106 [TBL] [Abstract][Full Text] [Related]
9. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. Gschwind A; Hart S; Fischer OM; Ullrich A EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035 [TBL] [Abstract][Full Text] [Related]
10. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. Lorenzen I; Lokau J; Düsterhöft S; Trad A; Garbers C; Scheller J; Rose-John S; Grötzinger J FEBS Lett; 2012 Apr; 586(8):1093-100. PubMed ID: 22575642 [TBL] [Abstract][Full Text] [Related]
11. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression. Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131 [TBL] [Abstract][Full Text] [Related]
12. ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. Wang Y; Zhang AC; Ni Z; Herrera A; Walcheck B J Immunol; 2010 Apr; 184(8):4447-54. PubMed ID: 20220092 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the role of the ADAM17-dependent secretome in cell signaling. Kawahara R; Lima RN; Domingues RR; Pauletti BA; Meirelles GV; Assis M; Figueira AC; Paes Leme AF J Proteome Res; 2014 Apr; 13(4):2080-93. PubMed ID: 24625128 [TBL] [Abstract][Full Text] [Related]
15. Status update on iRhom and ADAM17: It's still complicated. Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158 [TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Bech-Serra JJ; Santiago-Josefat B; Esselens C; Saftig P; Baselga J; Arribas J; Canals F Mol Cell Biol; 2006 Jul; 26(13):5086-95. PubMed ID: 16782893 [TBL] [Abstract][Full Text] [Related]
17. Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17. Yang Y; Wang Y; Zeng X; Ma XJ; Zhao Y; Qiao J; Cao B; Li YX; Ji L; Wang YL J Clin Endocrinol Metab; 2012 Aug; 97(8):E1390-401. PubMed ID: 22689693 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800 [TBL] [Abstract][Full Text] [Related]
20. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. Mu Y; Sundar R; Thakur N; Ekman M; Gudey SK; Yakymovych M; Hermansson A; Dimitriou H; Bengoechea-Alonso MT; Ericsson J; Heldin CH; Landström M Nat Commun; 2011; 2():330. PubMed ID: 21629263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]